Rose Shelley, Galland Barbara C, Styles Sara E, Wiltshire Esko J, Stanley James, de Bock Martin I, Tomlinson Paul A, Rayns Jenny A, Wheeler Benjamin J
Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Department of Pediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.
Pediatr Diabetes. 2023 Mar 28;2023:1842008. doi: 10.1155/2023/1842008. eCollection 2023.
The bidirectional relationship between sleep and blood glucose levels may particularly affect adolescents and young adults (AYA), who are more likely to experience less healthy glycemic outcomes and more disrupted sleep patterns. To date, few data exist describing the impact of intermittently scanned continuous glucose monitoring (isCGM) on habitual sleep patterns and sleep quality in AYA with type 1 diabetes (T1D).
To evaluate the impact of 6-month use of isCGM on habitual sleep and wake timing, sleep duration, frequency, and duration of night-time awakenings, sleep efficiency, and perceived sleep quality in young people with T1D and HbA1c ≥ 75 mmol/mol. The study recruited 64 participants aged 13-20 years (mean 16.6 ± 2.1), 48% female, diabetes duration 7.5 ± 3.8 years, 41% Māori or Pasifika, and a mean HbA1c 96.0 ± 18.0 mmol/mol [10.9 ± 3.8%]; 33 were allocated to an isCGM plus self-monitoring blood glucose [SMBG] intervention, and 31 were allocated to the SMBG control group.
Participants completed 7-day actigraphy measures and the Pittsburgh Sleep Quality Index questionnaire at the baseline and at 6 months. Regression analyses were used to model between-group comparisons, adjusted for baseline sleep measures.
At 6 months, subjective measures for overall sleep quality, latency, duration, efficiency, night-time disturbances, use of sleep medications, and daytime dysfunction were similar between the groups. Regression analyses of actigraphy found no significant differences in objectively measured sleep timing and duration across the week after adjusting for age, the period of the school year, and baseline sleep values.
The use of first-generation isCGM in addition to finger-prick testing did not impact objective or subjective sleep measures in AYA with T1D, elevated HbA1c, and highly variable sleep patterns. Research using alternative interventions for improving glycemic outcomes and habitual sleep-wake timing, duration, and perceived sleep quality is warranted in this population group.
睡眠与血糖水平之间的双向关系可能对青少年和青年(AYA)影响尤为显著,他们更有可能出现不太健康的血糖结果和更紊乱的睡眠模式。迄今为止,关于间歇性扫描式连续血糖监测(isCGM)对1型糖尿病(T1D)青少年和青年习惯性睡眠模式及睡眠质量影响的数据较少。
评估6个月使用isCGM对T1D且糖化血红蛋白(HbA1c)≥75 mmol/mol的年轻人习惯性睡眠和觉醒时间、睡眠时间、夜间觉醒频率和时长、睡眠效率以及主观睡眠质量的影响。该研究招募了64名年龄在13至20岁(平均16.6±2.1岁)的参与者,48%为女性,糖尿病病程7.5±3.8年,41%为毛利人或太平洋岛民,平均HbA1c为96.0±18.0 mmol/mol [10.9±3.8%];33人被分配到isCGM加自我监测血糖[SMBG]干预组,31人被分配到SMBG对照组。
参与者在基线和6个月时完成7天的活动记录仪测量以及匹兹堡睡眠质量指数问卷。采用回归分析对组间比较进行建模,并对基线睡眠测量值进行校正。
6个月时,两组在总体睡眠质量、入睡潜伏期、睡眠时间、效率、夜间干扰、睡眠药物使用和日间功能障碍等主观测量指标上相似。活动记录仪的回归分析发现,在调整年龄、学年时段和基线睡眠值后,一周内客观测量的睡眠时间和时长没有显著差异。
除指尖采血检测外,使用第一代isCGM对T1D、HbA1c升高且睡眠模式高度可变的青少年和青年的客观或主观睡眠指标没有影响。对于该人群,有必要开展使用替代干预措施来改善血糖结果以及习惯性睡眠-觉醒时间、时长和主观睡眠质量的研究。